Bel­licum slash­es 79% of staffers af­ter ear­ly da­ta quash hope around next-gen CAR-T

Bel­licum Phar­ma­ceu­ti­cals tried to make it work.

Over the past months the Hous­ton-based CAR-T play­er sold its man­u­fac­tur­ing fa­cil­i­ty to MD An­der­son — trans­fer­ring 35 em­ploy­ees …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER